Annual Cash & Cash Equivalents
$30.42 M
-$35.03 M-53.52%
December 31, 2022
Summary
- As of February 10, 2025, CTIC annual cash & cash equivalents is $30.42 million, with the most recent change of -$35.03 million (-53.52%) on December 31, 2022.
- During the last 3 years, CTIC annual cash & cash equivalents has fallen by -$724.00 thousand (-2.32%).
Performance
CTIC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$24.21 M
-$6.21 M-20.42%
March 31, 2023
Summary
- As of February 10, 2025, CTIC quarterly cash and cash equivalents is $24.21 million, with the most recent change of -$6.21 million (-20.42%) on March 31, 2023.
- Over the past year, CTIC quarterly cash and cash equivalents has dropped by -$72.69 million (-75.02%).
Performance
CTIC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CTIC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.5% | -75.0% |
| 3 y3 years | -2.3% | -70.2% |
| 5 y5 years | +11.8% | -76.9% |
CTIC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.5% | at low | -75.0% | at low |
| 5 y | 5-year | -53.5% | at low | -75.0% | at low |
| alltime | all time | -76.3% | -85.5% | -84.6% | -96.9% |
CTI BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $24.21 M(-20.4%) |
| Dec 2022 | $30.42 M(-53.5%) | $30.42 M(-5.1%) |
| Sep 2022 | - | $32.05 M(-51.5%) |
| Jun 2022 | - | $66.09 M(-31.8%) |
| Mar 2022 | - | $96.90 M(+48.1%) |
| Dec 2021 | $65.45 M(+62.0%) | $65.45 M(-31.3%) |
| Sep 2021 | - | $95.28 M(+32.5%) |
| Jun 2021 | - | $71.88 M(+117.1%) |
| Mar 2021 | - | $33.10 M(-18.0%) |
| Dec 2020 | $40.39 M(+29.7%) | $40.39 M(-10.8%) |
| Sep 2020 | - | $45.30 M(-35.4%) |
| Jun 2020 | - | $70.11 M(-13.6%) |
| Mar 2020 | - | $81.15 M(+160.6%) |
| Dec 2019 | $31.14 M(-14.5%) | $31.14 M(-10.8%) |
| Sep 2019 | - | $34.92 M(-1.3%) |
| Jun 2019 | - | $35.36 M(-12.9%) |
| Mar 2019 | - | $40.59 M(+11.4%) |
| Dec 2018 | $36.44 M(+33.9%) | $36.44 M(-31.1%) |
| Sep 2018 | - | $52.91 M(-19.1%) |
| Jun 2018 | - | $65.37 M(-37.5%) |
| Mar 2018 | - | $104.63 M(+284.4%) |
| Dec 2017 | $27.22 M(-38.1%) | $27.22 M(-48.5%) |
| Sep 2017 | - | $52.80 M(-29.4%) |
| Jun 2017 | - | $74.74 M(+124.6%) |
| Mar 2017 | - | $33.28 M(-24.4%) |
| Dec 2016 | $44.00 M(-65.7%) | $44.00 M(-28.6%) |
| Sep 2016 | - | $61.59 M(-19.7%) |
| Jun 2016 | - | $76.71 M(-26.7%) |
| Mar 2016 | - | $104.64 M(-18.4%) |
| Dec 2015 | $128.18 M(+80.7%) | $128.18 M(+176.5%) |
| Sep 2015 | - | $46.35 M(-15.5%) |
| Jun 2015 | - | $54.86 M(+23.6%) |
| Mar 2015 | - | $44.40 M(-37.4%) |
| Dec 2014 | $70.93 M(-1.0%) | $70.93 M(+137.2%) |
| Sep 2014 | - | $29.91 M(-9.9%) |
| Jun 2014 | - | $33.18 M(-34.4%) |
| Mar 2014 | - | $50.60 M(-29.4%) |
| Dec 2013 | $71.64 M(+42.0%) | $71.64 M(+163.6%) |
| Sep 2013 | - | $27.18 M(-4.9%) |
| Jun 2013 | - | $28.57 M(-35.5%) |
| Mar 2013 | - | $44.31 M(-12.1%) |
| Dec 2012 | $50.44 M(+7.2%) | $50.44 M(+253.0%) |
| Sep 2012 | - | $14.29 M(-3.2%) |
| Jun 2012 | - | $14.76 M(-46.1%) |
| Mar 2012 | - | $27.38 M(-41.8%) |
| Dec 2011 | $47.05 M(+107.7%) | $47.05 M(+4.1%) |
| Sep 2011 | - | $45.21 M(+16.3%) |
| Jun 2011 | - | $38.89 M(-11.2%) |
| Mar 2011 | - | $43.81 M(+93.4%) |
| Dec 2010 | $22.65 M(-40.1%) | $22.65 M(+31.2%) |
| Sep 2010 | - | $17.27 M(-73.2%) |
| Jun 2010 | - | $64.53 M(+55.5%) |
| Mar 2010 | - | $41.51 M(+9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $37.81 M(+275.4%) | $37.81 M(-31.2%) |
| Sep 2009 | - | $54.99 M(+359.0%) |
| Jun 2009 | - | $11.98 M(+1501.6%) |
| Mar 2009 | - | $748.00 K(-92.6%) |
| Dec 2008 | $10.07 M(-36.2%) | $10.07 M(-4.3%) |
| Sep 2008 | - | $10.53 M(+123.9%) |
| Jun 2008 | - | $4.70 M(-65.4%) |
| Mar 2008 | - | $13.60 M(-13.9%) |
| Dec 2007 | $15.80 M(-7.8%) | $15.80 M(+35.0%) |
| Sep 2007 | - | $11.70 M(+45.8%) |
| Jun 2007 | - | $8.03 M(-27.2%) |
| Mar 2007 | - | $11.03 M(-35.6%) |
| Dec 2006 | $17.13 M(-65.8%) | $17.13 M(+6.2%) |
| Sep 2006 | - | $16.13 M(-47.4%) |
| Jun 2006 | - | $30.68 M(+26.3%) |
| Mar 2006 | - | $24.30 M(-51.4%) |
| Dec 2005 | $50.02 M(-52.4%) | $50.02 M(+53.0%) |
| Sep 2005 | - | $32.69 M(+24.6%) |
| Jun 2005 | - | $26.24 M(-29.7%) |
| Mar 2005 | - | $37.35 M(-64.4%) |
| Dec 2004 | $105.03 M(+1144.8%) | $105.03 M(+92.6%) |
| Sep 2004 | - | $54.53 M(-35.3%) |
| Jun 2004 | - | $84.25 M(-12.5%) |
| Mar 2004 | - | $96.31 M(+1041.4%) |
| Dec 2003 | $8.44 M(-53.0%) | $8.44 M(-40.8%) |
| Sep 2003 | - | $14.25 M(-78.7%) |
| Jun 2003 | - | $66.98 M(+511.8%) |
| Mar 2003 | - | $10.95 M(-39.0%) |
| Dec 2002 | $17.95 M(-53.6%) | $17.95 M(-36.7%) |
| Sep 2002 | - | $28.37 M(-54.8%) |
| Jun 2002 | - | $62.78 M(+132.0%) |
| Mar 2002 | - | $27.06 M(-30.1%) |
| Dec 2001 | $38.69 M(+63.0%) | $38.69 M(-61.9%) |
| Sep 2001 | - | $101.58 M(-35.6%) |
| Jun 2001 | - | $157.65 M(+517.7%) |
| Mar 2001 | - | $25.52 M(+7.5%) |
| Dec 2000 | $23.73 M(+316.4%) | $23.73 M(-82.5%) |
| Sep 2000 | - | $135.60 M(+1047.6%) |
| Jun 2000 | - | $11.82 M(-60.5%) |
| Mar 2000 | - | $29.89 M(+424.4%) |
| Dec 1999 | $5.70 M(+29.5%) | $5.70 M(+35.7%) |
| Sep 1999 | - | $4.20 M(+27.3%) |
| Jun 1999 | - | $3.30 M(-5.7%) |
| Mar 1999 | - | $3.50 M(-20.5%) |
| Dec 1998 | $4.40 M(-50.6%) | $4.40 M(-55.6%) |
| Sep 1998 | - | $9.90 M(+167.6%) |
| Jun 1998 | - | $3.70 M(-28.8%) |
| Mar 1998 | - | $5.20 M(-41.6%) |
| Dec 1997 | $8.90 M(+61.8%) | $8.90 M(+14.1%) |
| Sep 1997 | - | $7.80 M(+136.4%) |
| Jun 1997 | - | $3.30 M(-90.3%) |
| Mar 1997 | - | $34.10 M |
| Dec 1996 | $5.50 M | - |
FAQ
- What is CTI BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CTI BioPharma?
- What is CTI BioPharma annual cash & cash equivalents year-on-year change?
- What is CTI BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CTI BioPharma?
- What is CTI BioPharma quarterly cash and cash equivalents year-on-year change?
What is CTI BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of CTIC is $30.42 M
What is the all time high annual cash & cash equivalents for CTI BioPharma?
CTI BioPharma all-time high annual cash & cash equivalents is $128.18 M
What is CTI BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, CTIC annual cash & cash equivalents has changed by -$35.03 M (-53.52%)
What is CTI BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CTIC is $24.21 M
What is the all time high quarterly cash and cash equivalents for CTI BioPharma?
CTI BioPharma all-time high quarterly cash and cash equivalents is $157.65 M
What is CTI BioPharma quarterly cash and cash equivalents year-on-year change?
Over the past year, CTIC quarterly cash and cash equivalents has changed by -$72.69 M (-75.02%)